Sundell KL - Search Results

1

Effects of first-trimester fluoxetine exposure on the newborn.

Goldstein DJ, Corbin LA, Sundell KL. Goldstein DJ, et al. Among authors: sundell kl. Obstet Gynecol. 1997 May;89(5 Pt 1):713-8. doi: 10.1016/s0029-7844(97)00070-7. Obstet Gynecol. 1997. PMID: 9166307

2

Birth outcomes in pregnant women taking fluoxetine.

Goldstein DJ, Sundell KL, Corbin LA. Goldstein DJ, et al. Among authors: sundell kl. N Engl J Med. 1997 Mar 20;336(12):872-3; author reply 873. N Engl J Med. 1997. PMID: 9072683 No abstract available.

3

Determination of pregnancy outcome risk rates after exposure to an intervention.

Goldstein DJ, Sundell KL, DeBrota DJ, Offen WW. Goldstein DJ, et al. Among authors: sundell kl. Clin Pharmacol Ther. 2001 Jan;69(1):7-13. doi: 10.1067/mcp.2001.112364. Clin Pharmacol Ther. 2001. PMID: 11180033 No abstract available.

4

The role of fluoxetine in the treatment of premenstrual dysphoric disorder.

Romano S, Judge R, Dillon J, Shuler C, Sundell K. Romano S, et al. Clin Ther. 1999 Apr;21(4):615-33; discussion 613. doi: 10.1016/S0149-2918(00)88315-0. Clin Ther. 1999. PMID: 10363729 Review.

5

Changes in weight during a 1-year trial of fluoxetine.

Michelson D, Amsterdam JD, Quitkin FM, Reimherr FW, Rosenbaum JF, Zajecka J, Sundell KL, Kim Y, Beasley CM Jr. Michelson D, et al. Among authors: sundell kl. Am J Psychiatry. 1999 Aug;156(8):1170-6. doi: 10.1176/ajp.156.8.1170. Am J Psychiatry. 1999. PMID: 10450256 Clinical Trial.

6

Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.

Cohen LS, Miner C, Brown EW, Freeman E, Halbreich U, Sundell K, McCray S. Cohen LS, et al. Obstet Gynecol. 2002 Sep;100(3):435-44. doi: 10.1016/s0029-7844(02)02166-x. Obstet Gynecol. 2002. PMID: 12220761 Clinical Trial.

7

The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France.

Hylan TR, Sundell K, Judge R. Hylan TR, et al. J Womens Health Gend Based Med. 1999 Oct;8(8):1043-52. doi: 10.1089/jwh.1.1999.8.1043. J Womens Health Gend Based Med. 1999. PMID: 10565662

8

Changes in adverse events reported by patients during 6 months of fluoxetine therapy.

Zajecka J, Amsterdam JD, Quitkin FM, Reimherr FW, Rosenbaum JF, Tamura RN, Sundell KL, Michelson D, Beasley CM Jr. Zajecka J, et al. Among authors: sundell kl. J Clin Psychiatry. 1999 Jun;60(6):389-94. doi: 10.4088/jcp.v60n0608. J Clin Psychiatry. 1999. PMID: 10401918 Clinical Trial.

9

Safety profile of Alzheimer's disease populations in Alzheimer's Disease Neuroimaging Initiative and other 18-month studies.

Henley DB, Sundell KL, Sethuraman G, Siemers ER; Alzheimer's Disease Neuroimaging Initiative. Henley DB, et al. Among authors: sundell kl. Alzheimers Dement. 2012 Sep;8(5):407-16. doi: 10.1016/j.jalz.2011.05.2413. Epub 2011 Dec 3. Alzheimers Dement. 2012. PMID: 22138370

10

Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor.

Slieker LJ, Brooke GS, DiMarchi RD, Flora DB, Green LK, Hoffmann JA, Long HB, Fan L, Shields JE, Sundell KL, Surface PL, Chance RE. Slieker LJ, et al. Among authors: sundell kl. Diabetologia. 1997 Jul;40 Suppl 2:S54-61. doi: 10.1007/s001250051402. Diabetologia. 1997. PMID: 9248702

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page